Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Share News (OBD)

Share Price Information for Oxford Biodyn (OBD)

Share Price is delayed by 15 minutes
Get Live Data
0.19    0.00 (0.00%)
Bid:
0.18
Ask:
0.20
Spread: 0.02 (11.111%)
Market Cap: £8.15m
OBD Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biodyn Share Chart

Oxford Biodyn News

Oxford BioDynamics raises £7.35m through placing, subscription and retail offer
17 Jan 2025

Oxford BioDynamics raises £7.35m through placing, subscription and retail offer

(Sharecast News) - Oxford BioDynamics, a precision clinical diagnostics company leveraging its 'EpiSwitch 3D' genomics platform, announced the success...

IN BRIEF: Oxford BioDynamics launches GBP6.5 million fund raise
14 Jan 2025

IN BRIEF: Oxford BioDynamics launches GBP6.5 million fund raise

Oxford BioDynamics PLC - Oxford, England-based biotechnology company has two blood testing products on market, the PSE prostate cancer screening test ...

Oxford Biodynamics CEO resigns as it seeks short-term funding
16 Dec 2024

Oxford Biodynamics CEO resigns as it seeks short-term funding

(Sharecast News) - Clinical diagnostics specialist Oxford BioDynamics announced on Monday that Dr Jon Burrows had resigned from his positions as chief...

LONDON MARKET CLOSE: Stocks climb as PM says UK is open for business
14 Oct 2024

LONDON MARKET CLOSE: Stocks climb as PM says UK is open for business

(Alliance News) - London's FTSE 100 closed higher on Monday, although bookmakers suffered, as the UK prime minister played down rumours of a capital g...

Oxford BioDynamics pledges to cut costs amid need to raise extra funds
14 Oct 2024

Oxford BioDynamics pledges to cut costs amid need to raise extra funds

(Alliance News) - Oxford BioDynamics PLC on Monday launched a strategic review after warning it would need additional cash resources by early 2025.

Oxford BioDynamics revenue up 49% in first half as test sales rise
18 Jun 2024

Oxford BioDynamics revenue up 49% in first half as test sales rise

(Alliance News) - Oxford BioDynamics PLC on Tuesday reported strong revenue growth on the back of the increased commercialisation of its EpiSwitch gen...

Oxford BioDynamics develops canine cancer test with 89% accuracy
4 Jun 2024

Oxford BioDynamics develops canine cancer test with 89% accuracy

(Alliance News) - Oxford BioDynamics PLC on Tuesday announced the development of a canine cancer diagnostic test based on its EpiSwitch non-invasive p...